Taiwan FDA registration 5b5868963c0d35fe1e39970ef86aabf8

Mei Ariel Ji Yazi Eight Drug Abuse Test Kits

TW: 美艾利爾 揣耶濟 八類藥物濫用檢測套組
Taiwan flagTaiwan·Risk Class 2·ALERE SAN DIEGO, INC.·Registered Mar 21, 2006 – Mar 21, 2021Cancelled
Registration details
Analysis ID
5b5868963c0d35fe1e39970ef86aabf8
Customs Code
DHA00601617900
Company information
Manufacturer Country
United States
Authorized Representative
Abbott Rapid Diagnostics Health Corp.
Product details
Intended Use
Urine is qualitatively detected for amphetamines, barbiturates, benzodiazepines, cocaine, methadone, opium, tetrahydrocanabinol and their metabolites, and the presence of tricyclic antidepressants at specific cut-off values.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.3100 Anandamide Test System
Import Information
import
Dates and status
Registration Date
Mar 21, 2006
Expiry Date
Mar 21, 2021
Cancellation Date
Oct 12, 2023
Cancellation information
Status
Logged out
Reason
未展延而逾期者
About this record

Access comprehensive regulatory information for Mei Ariel Ji Yazi Eight Drug Abuse Test Kits in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5b5868963c0d35fe1e39970ef86aabf8 and manufactured by ALERE SAN DIEGO, INC.. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices